Anticorps anti-glycoconjugues et neuropathies peripheriques dysglobulinemiques ou dysimmunitaires. [Anti-glycoconjugate antibodies and dysglobulinemic or dysimmune peripheral neuropathies]

Détails

ID Serval
serval:BIB_7E6722DCB739
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Anticorps anti-glycoconjugues et neuropathies peripheriques dysglobulinemiques ou dysimmunitaires. [Anti-glycoconjugate antibodies and dysglobulinemic or dysimmune peripheral neuropathies]
Périodique
Revue Neurologique
Auteur(s)
Steck  A. J., Kuntzer  T.
ISSN
0035-3787 (Print)
Statut éditorial
Publié
Date de publication
05/1996
Peer-reviewed
Oui
Volume
152
Numéro
5
Pages
400-4
Notes
English Abstract Journal Article Review --- Old month value: May
Résumé
Different anti-glycoconjugate auto-antibodies are described to be associated with peripheral neuropathies; the anti-MAG monoclonal IgM activity is determined by ELISA or immunoblotting essays, anti-glycolipid activity by ELISA or chromatography and monoclonal gammopathies by commercially available kits. These investigations are limited by possible cross-reactions due to the common glycosilate epitope. The peripheral neuropathies with anti-glycoconjugate auto-antibodies are different: Guillain-Barre syndrome and its variants (anti-GM1, GQ1b, LM1, GD1, GD1a gangliosides or sulfatides), motor neuropathy (anti-GM1 ganglioside), sensory neuropathies (anti-GD3, GD1b, GD1a, GQ1b gangliosides or sulfatides), and chronic myelinic neuropathy with IgM gammopathy (anti-MAG). We review the major clinical and electrophysiological features and discuss the underlying pathophysiological mechanisms.
Mots-clé
*Autoantibodies/analysis Glycoconjugates/*immunology Humans Peripheral Nervous System Diseases/diagnosis/*immunology/physiopathology
Pubmed
Web of science
Création de la notice
25/01/2008 13:43
Dernière modification de la notice
03/03/2018 18:41
Données d'usage